News from the web:
Still relatively little is known about exactly what makes Alzheimer’s disease destroy the brain. Now scientists have at least agreed that two proteins, that long have had separate research groups looking at them, together are a major cause of Alzheimer’s and that our best bet to fight off Alzheimer’s may well be to prevent both proteins from developing their harmful works.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Here is a couple that has put on more than 500 musical shows in assisted living homes to aid people with Alzheimer. People react to music and participation is strongly encouraged.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Often I wonder how our wonderful scientists get the ideas for their research. It is not clear to me how a group of researchers came to feed mice with a piece that comes from the dirt on Easter Island, only to discover it may help people who suffer from Alzheimer.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Today we refer you to a great short and concise article by Glenn E. Smith, PhD, where he explains the causes, Prevention, Diagnosis and Treatment of Alzheimer.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
There are several theories on how coconut oil might work in Alzheimer’s disease, but nothing has been proven. Unfortunately, too, the studies have included very few patients: 23 in one six-week study and 20 in another. One article that I reviewed on the use of coconut oil could find no peer-reviewed clinical studies on its use in AD. The company that manufactures Axona studied 152 patients for 90 days. Although the company claimed benefit, at 90 days both those who were taking coconut oil, and those who were not, had similar testing scores.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Here is some good news about the fight against Alzheimer. Scientist have declared a human trail successful. The new treatment involves active immunisation, using a type of vaccine designed to trigger the body’s immune defence against beta-amyloid.
In this second clinical trial on humans, the vaccine was modified to affect only the harmful beta-amyloid.
The researchers found that 80 per cent of the patients involved in the trials developed their own protective antibodies against beta-amyloid without suffering any side effects over the three years of the study.
Read all about it HERE
visit us at AlzheimerHeadlines.com